×

Ackman explains Valeant bid

7:52 AM ET Mon, 9 June 2014

Bill Ackman, founder and CEO of Pershing Square Capital Management, answers why he thinks Valeant's potential takeover of Allergan is beneficial, and the 'unprecedented' terms in the bid.